Coltene Holding AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0025343259
CHF
52.70
0.1 (0.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Coltene Holding AG stock-summary
stock-summary
Coltene Holding AG
Pharmaceuticals & Biotechnology
Coltene Holding AG is a Switzerland-based Company active in the healthcare sector. It develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. It has production facilities in Switzerland, the United States, Germany and Hungary. The Company's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.
Company Coordinates stock-summary
Company Details
Feldwiesenstrasse 20 , ALTSTAETTEN None : 9450
stock-summary
Tel: 41 71 757538041 71 7575437
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Nick Huber
Non-Executive Chairman of the Board of Directors
Mr. Erwin Locher
Non-Executive Member of the Board of Directors
Mr. Juergen Rauch
Non-Executive Member of the Board of Directors
Mr. Matthew Robin
Non-Executive Member of the Board of Directors
Dr. Astrid Waser
Non-Executive Member of the Board of Directors
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 304 Million ()

stock-summary
P/E

19.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.91%

stock-summary
Debt Equity

0.38

stock-summary
Return on Equity

15.83%

stock-summary
Price to Book

3.36